Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer JCN Newswire

Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer

Strasbourg, France & Schiphol, Netherlands, Apr 3, 2026 - (JCN Newswire via SeaPRwire.com) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Bio B.V. ("NEC"), a wholly owned subsidiary of NEC Corporation (TSE: 6701), a leader in IT, network and AI technologies, announce the signing of a license agreement to advance the clinical development of TG4050, an individualized neoantigen therapeutic vaccine (INTV) in the adjuvant treatment of resected HPV-negative head and neck cancer.TG4050 is an individualized immunotherapy based on an MVA viral vector incorporating neoantigens selected using NEC’s AI-enabled prediction platform. It is currently being evaluated in patients with head and neck cancer with the aim of preventing relapse and extend disease-free survival following surgery and adjuvant therapy. TG4050 is designed to stimulate and educate the immune system against a patient’s cancer using tumor-specific genetic mutations (neoantigens) targeting each patient’s unique tumor. These neoantigens are identified and selected using NEC’s proprietary platform, which applies advanced machine learning to select immunogenic mutations that are most likely to induce a strong immune response.Under the terms of the license agreement, Transgene secures access to NEC’s AI-based neoantigen prediction platform for further development of TG4050 in the adjuvant treatment of resected HPV-negative head and neck cancer while conferring rights to enable Transgene’s further clinical development and to support commercialization and potential partnering of the program. NEC retains full ownership and operational control of its AI platform and will support Transgene to conduct further clinical activity.NEC will receive a technology access fee of €2.5 million in Transgene shares following the signing (see below) and an additional €2.5 million in cash to be paid out in a series of tranches through early 2028. Additionally, a further payment will be milestone-based and a portion of such payment will be made in Transgene’ shares. NEC is also eligible to receive undisclosed additional consideration including development milestone payments, as well as a double-digit share of profits or licensing revenues."Building on the results of our long-standing collaboration and with the license to use NEC’s prediction platform, we are now in a strong position to pursue further development of TG4050, which will be informed by data from our ongoing Phase 2 trial. We are also pleased to welcome NEC as a shareholder of Transgene and appreciate their confidence as we work together to advance a treatment that has the potential to improve the outcomes for patients at risk of relapse in head and neck cancer," said Dr. Alessandro Riva, Chairman and CEO of Transgene.Akira Kitamura, GM, AI Drug Development Division of NEC Corporation and CEO of NEC Bio, added, "This agreement is an important milestone in our partnership with Transgene and reflects NEC’s long-term commitment to the development of TG4050. This collaboration is a clear example of how NEC can bring differentiated AI capabilities to biopharma. The clinical data generated to date is encouraging and support the potential of TG4050 as a promising approach to reducing relapse risk in patients with head and neck cancer. We look forward to deepening our collaboration with Transgene and to realizing the full clinical and strategic potential of this partnership."Capital increaseAs indicated above, a €2.5 million portion of the access fee to be paid to NEC will be paid in Transgene shares. Transgene will thus issue 3,345,824 new shares to NEC Bio B.V. at a price of €0.7472 per share. This price corresponds to the volume-weighted average (VWAP) of the last five (5) closing prices of the Transgene shares on the regulated market of Euronext in Paris prior to signing. The new shares will represent 1.22% of the share capital of Transgene post issuance (and 0.98% of its voting rights)1.The capital increase is carried out on the basis of the 22nd resolution of the Combined General Meeting of May 15, 2025. The new shares will be admitted to trading on the regulated market of Euronext in Paris as soon as they are issued and will be immediately assimilated to the existing Transgene shares (ISIN code FR0005175080).The capital increase is expected to be completed by the end of April 2026.(1) Based on today’s share capital and voting rights.ShareAbout TG4050TG4050 is an individualized immunotherapy being developed in the treatment of resected HPV-negative head and neck cancer that is based on Transgene’s myvac® technology and powered by NEC’s longstanding artificial intelligence (AI) and machine learning (ML) expertise. This virus-based individualized neoantigen therapeutic vaccine (INTV) encodes neoantigens (patient-specific mutations) identified and selected by NEC’s Neoantigen Prediction System. The prediction system is based on more than two decades of expertise in AI and has been trained on proprietary data allowing it to prioritize and select the sequences that are predicted to be the most immunogenic sequences.TG4050 is designed to stimulate the immune system of patients in order to induce a T-cell response that is able to recognize and destroy tumor cells based on their own neoantigens. This individualized immunotherapy is developed and produced for each patient.About TransgeneTransgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. The Company’s clinical-stage programs consist of a portfolio of viral vector-based immunotherapeutics. TG4050, the first individualized therapeutic vaccine based on the myvac® platform is the Company’s lead asset, with demonstrated proof of principle in patients in the adjuvant treatment of head and neck cancers. The Company has other viral vector-based assets, including BT-001, an oncolytic virus based on the Invir.IO® viral backbone, which is in clinical development. The Company also conducts innovative discovery and preclinical work, aimed at developing novel immunotherapies.With Transgene’s myvac® platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully tailored to each individual. The myvac® approach allows the generation of a virus-based immunotherapy that encodes patient-specific mutations identified and selected by Artificial Intelligence capabilities provided by its partner NEC.Additional information about Transgene is available at: www.transgene.comFollow us on social media: X: @TransgeneSA — LinkedIn: @Transgene — Bluesky: @TransgeneAbout NEC CorporationThe NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group’s approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society. For more information, please visit https://www.nec.com, follow us on Instagram, Facebook, and LinkedIn.About NEC BioNEC Bio is the biotechnology arm of NEC Corporation, headquartered in the Netherlands, and focused on leveraging state of the art AI technologies to address world's most pressing healthcare challenges. Leveraging cutting-edge science, data, and innovation, NEC Bio is dedicated to developing personalized therapies designed to transform patient outcomes and improve quality of life globally. With a growing international footprint, NEC Bio includes subsidiaries such as NEC OncoImmunity in Oslo, Norway, and NEC Bio Therapeutics in Mannheim, Germany—each contributing specialized expertise across immunotherapy, precision medicine, and translational research. Together, these entities form a collaborative ecosystem committed to accelerating innovation from discovery to patient impact.To learn more, visit www.nec-bio.com and follow us on LinkedIn for the latest updates.DisclaimerThis press release contains forward-looking statements, which are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. The occurrence of any of these risks could have a significant negative outcome for the Company’s activities, perspectives, financial situation, results, regulatory authorities’ agreement with development phases, and development. The Company’s ability to commercialize its products depends on but is not limited to the following factors: positive pre-clinical data may not be predictive of human clinical results, the success of clinical studies, the ability to obtain financing and/or partnerships for product manufacturing, development and commercialization, and marketing approval by government regulatory authorities. For a discussion of risks and uncertainties which could cause the Company’s actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Universal Registration Document, available on the AMF website (http://www.amf-france.org) or on Transgene’s website (www.transgene.com). Forward-looking statements speak only as of the date on which they are made, and Transgene undertakes no obligation to update these forward-looking statements, even if new information becomes available in the future. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut
Hitachi Rail announces agreement to acquire Clever Devices, marking its growth as a global digital mobility player JCN Newswire

Hitachi Rail announces agreement to acquire Clever Devices, marking its growth as a global digital mobility player

NEW YORK, Apr 3, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Rail has entered into a definitive agreement to acquire Clever Devices, a leading U.S. - based provider of Intelligent Transportation Systems for transit agencies around the world.Clever Devices, headquartered in Woodbury, New York, is recognized for its pioneering, advanced technology solutions that enhance fleet management, passenger experience and operational efficiency for mass transit agencies. The company has offices located in the United States, Europe, and South America.The proposed acquisition of a company with deep digital expertise and expected 2026 revenues of over $220 million, marks a significant step in Hitachi Rail’s strategy to operate as a leading global digital mobility player. Upon completion, the business will extend its footprint from rail to multimodal mobility and strengthen its presence in North America.With over 600 employees and a customer base that includes 8 of the 10 largest North American transit agencies, Clever Devices brings a robust portfolio and a proven track record of innovation and delivery. Its Intelligent Transport System (ITS) solutions are a critical enabler to growing public transport usage, making it more attractive and efficient by improving accuracy of information and boosting service punctuality. Its solutions are deployed across public mobility, including busses, as well as railway systems. Alongside its strength in North America, Clever Devices has achieved substantial growth in countries such as Brazil and Chile, as well as in Europe in markets including Italy.Clever Devices’ portfolio of onboard and centralized data solutions will complement Hitachi Rail’s HMAX Mobility suite, bringing added functionality and benefits for customers across public transport around the world.HMAX Mobility is Hitachi Rail’s digital asset management platform that optimizes the performance of railways around the world. It connects data from fleets of trains, wayside signal ling assets, and track infrastructure to create an operational twin of railways. It brings together advanced sensor technology, deep rail expertise and the latest in AI and edge computing to maximize rail performance, extend asset life and optimize costs.The acquisition will enable Hitachi Rail to offer enhanced solutions that support the digital transformation of public transport beyond railways, optimize energy management and contribute to the reduction of greenhouse gas emissions.In the Smart Mobility space, combining Clever Devices’ fleet management technology with Hitachi Rail’s Operation Control Centres will enable real time multimodal solutions for urban public transport systems. This technology will enable connected and sustainable intermodal transport and support the transition to more sustainable and efficient transit systems.Giuseppe Marino, Group CEO, Hitachi Rail, said: “This investment is an important milestone in our strategy to accelerate the digital transformation of public mobility. Clever Devices’ proven expertise in intelligent transportation systems, combined with our global scale and our HMAX Mobility platform, will allow us to offer our customers a suite of data - driven mobility solutions that optimize transport infrastructure and services. Together, we will expand our capabilities beyond rail and deepen our presence in North America, supporting cities as they transition to more innovative and efficient transport networks.”Hitachi Rail’s growing footprint in the North American market has been underlined by the recent $110m opening of its digital lighthouse factory in Hagerstown, Maryland, and a CA $30m investment in a new Canadian HQ.Hitachi Rail collaborated with SSIB, Hitachi’s Strategic Social Innovation Business Unit, on this agreement, to jointly advance the One Hitachi initiative and explore broader opportunities in the mobility sector. As a Hitachi Group company, Hitachi Rail’s pioneering technology also benefits from the digital expertise and capabilities of other group companies, including Hitachi Digital, GlobalLogic, and Hitachi Digital Services.The transaction is subject to the satisfaction of customary conditions and is expected to close later in the year following the receipt of regulatory approvals. Hitachi Rail is being advised by J.P. Morgan and Ropes & Gray LLP in this transaction.About Clever DevicesTotal employees: 600 employeesFounded Around: 1987Locations: Headquartered in New York, with offices across the US, Canada, Brazil and Italy.Customers: Over 250 worldwide, including 8 of the 10 largest transit agencies in North America. Customers span public transport including bus, railway and paratransit operatorsRevenues: Expected Revenues of over$220 million in 2026Clever Devices’ Solutions: Fleet monitoring solutions including Automatic Vehicle Monitoring (providing single source of diagnostic information); Clever CAD (communications tool between operator and vehicles); Clever Works (maximizing integrity and efficiency of data); Electric Vehicle Management Solution Passenger facing solutions, including: Live bus time updates; Automated Voice Announcement; Clever Vision (real time information to passengers on board) As well as Safety and security; Business Intelligence; and Communications solutionsAbout Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY 2024 (ended March 31, 2025) totaled 9,783. 3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com.About Hitachi RailHitachi Rail is committed to driving the transition to sustainable mobility and has a clear focus on partnering with customers to rethink mobility. Its mission is to help every passenger, customer, and community enjoy the benefits of more connected, smooth , and sustainable transportation. With a turnover of more than €7 billion and 24,000 employees in more than 50 countries, Hitachi Rail is a reliable partner for the world's best transport companies. The company's presence is global, but the company is local, with success based on developing local talent and investing in people and communities. Its international expertise and experience covers every part of urban ecosystems, main lines and freight railways, from high - quality production and maintenance of rolling stock to digital signalling, payment systems and smart operations. Hitachi Rail, famous for Japan's iconic high -speed train, leverages the digital and artificial intelligence expertise of Hitachi Group companies to accelerate innovation and develop new technologies. For more information, visit the hitachirail.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut
Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026 ACN Newswire

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026

PHILADELPHIA, PA, Apr 3, 2026 - (ACN Newswire via SeaPRwire.com) - Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that CEO Nathaniel (Nate) T. Bradley will present and exhibit the Company's DataValue®, DataScore®, Data Vault Bank® AI Agent, and patented Information Data Exchange® technologies at XRP Tokyo 2026 on April 7, 2026, at Happo-en in Tokyo, Japan.Bradley's presentation, "Data-Driven RWA Tokenization: Unlocking Japan's Trillion-Yen Opportunity on the XRP Ledger," will demonstrate how Datavault AI's platforms support secure, AI-powered tokenization of real estate, commodities, and other high-value assets in Japan's regulation-friendly market.Japan has emerged as Asia's leading real-world asset tokenization market, with institutional platforms such as Progmat (MUFG-backed) managing approximately ¥440 billion (~$2.8 billion USD) in tokenized assets, primarily real estate and corporate bonds. Broader public STO (Security Token Offering) activity has reached the $1.3-2 billion+ range, with the sector projected to exceed ¥1 trillion (~$6-7 billion) by the end of 2026. Recent momentum includes MUFG's March 2026 launch of its ¥22.4 billion (~$142 million) Osaka Dojimahama Tower real estate security token, one of the largest single issuances to date."Japan's institutional adoption of tokenized real-world assets, combined with clear regulatory frameworks, creates exceptional opportunities for scalable licensing and customer partnerships," said Nathaniel Bradley, CEO of Datavault AI. "At XRP Tokyo, we'll demonstrate how our AI-powered data valuation and tokenization infrastructure can help Japanese institutions unlock liquidity in real estate, commodities, and other high-value assets. We're focused on building long-term commercial relationships across the APAC region that translate into meaningful revenue opportunities for Datavault AI."Hosted by XRPL Japan as part of the TEAMZ Web3/AI Summit 2026, XRP Tokyo 2026 brings together developers, enterprises, investors, and institutions to explore real-world blockchain applications, including tokenization, payments, and digital asset infrastructure.Datavault AI's participation builds on its growing momentum in RWA tokenization and reflects its strategic focus on APAC market expansion and international customer development.About Datavault AI Inc.Datavault AI TM (NASDAQ:DVLT) is leading the way in AI-driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. The Company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions.Datavault AI's Acoustic Sciences division features WiSA®, ADIO®, and Sumerian® patented technologies and industry-first foundational spatial and multichannel wireless, high-definition sound transmission technologies with intellectual property covering audio timing, synchronization, and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization.Datavault AI's platform serves multiple industries, including high-performance computing software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy, and more. The Information Data Exchange® enables Digital Twins and the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity. The Company's technology suite is fully customizable and offers AI- and machine-learning-based automation, third-party integration, detailed analytics and data, marketing automation, and advertising monitoring.The Company is headquartered in Philadelphia, PA. Learn more about Datavault AI at https://datavaultsite.comAbout XRP Tokyo 2026XRP Tokyo 2026 is Japan's premier XRP-focused conference, taking place April 7, 2026, at Happo-en, Tokyo. Hosted by XRPL Japan, the event showcases the XRP Ledger's role in institutional adoption and real-world blockchain innovation. More information: xrp-tokyo.io.Market Data SourcesJapan real-world asset tokenization market data: "Progmat Pivots to Public Chain: Migrates 440 Billion Yen in Security Token Assets to Avalanche," FinTech Observer, February 26, 2026 (https://www.fintechobserver.com/progmat-pivots-to-public-chain-migrates-440-billion-yen-in-security-token-assets-to-avalanche/); "MUFG Enters $1.3 Billion Japan Security Token Market," BeInCrypto, October 10, 2025 (https://beincrypto.com/mufg-enters-1-3-billion-japan-security-token-market/); "BOOSTRY Publishes Japan Security Token Market Report (FY2024)," Nomura Holdings, April 2, 2025 (https://www.nomuraholdings.com/en/news/nr/news202504022.html); "Progmat Migrates $2B+ of its Tokenized Securities to Avalanche," Avax.network, February 25, 2026 (https://www.avax.network/about/blog/progmat-migrates-2b-tokenized-securities-to-avalanche); "MUFG launches first own brand real estate security token for $142 million," Ledger Insights, March 2026 (https://www.ledgerinsights.com/mufg-launches-first-own-brand-real-estate-security-token-for-142-million/).Forward-Looking StatementsThis press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws) about Datavault AI Inc. ("Datavault AI," the "Company," "us," "our," or "we") and our industry that involve risks and uncertainties. In some cases, you can identify forward-looking statements because they contain words, such as "may," "might," "will," "shall," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "goal," "objective," "seeks," "likely" or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. The absence of these words does not mean that a statement is not forward-looking. Such forward-looking statements, including, but not limited to, statements regarding future events, the creation of opportunities for scalable licensing and customer partnerships as a result of Japan's institutional adoption of tokenized RWAs, and how the Company's AI-powered data valuation and tokenization infrastructure can help Japanese institutions unlock liquidity in real estate, commodities and other high-value assets, and expected operational, technical, and commercial outcomes of the Company's commercial strategy, and the projected direction and market impacts of regulatory changes with respect to digital assets, are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management, are inherently uncertain.Readers are cautioned not to place undue reliance on these and other forward-looking statements contained herein.Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: the Company's ability to create opportunities for scalable licensing and customer partnerships as a result of Japan's institutional adoption of tokenized RWAs; the Company's ability to help Japanese institutions unlock liquidity in real estate, commodities and other high-value assets through its AI-powered data valuation and tokenization infrastructure; changes in market demand for Datavault AI's services and products; changes in economic, market, or regulatory conditions; risks relating to evolving regulatory frameworks applicable to tokenized assets; risks associated with technological development and integration; and other risks and uncertainties as more fully described in Datavault AI's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025 and other filings that Datavault AI makes from time to time with the SEC, which are available on the SEC's website at www.sec.gov, and could cause actual results to vary from expectations.The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Datavault AI undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.Datavault AI may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Datavault AI's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments it may make.Industry and Market DataWithin this press release, we reference information and statistics regarding the market for our products. We have obtained some of this information and statistics from various independent third-party sources, including independent industry publications, reports by market research firms and other independent sources. Some data and other information contained in this press release are also based on management's estimates and calculations, which are derived from our review and interpretation of internal surveys and independent sources. Data regarding the industries in which we compete and our market position and market share within these industries are inherently imprecise and are subject to significant business, economic and competitive uncertainties beyond our control, but we believe they generally indicate size, position and market share within this industry. While we believe such information is reliable, we have not independently verified any third-party information. While we believe our internal company research and estimates are reliable, such research and estimates have not been verified by any independent source. In addition, assumptions and estimates of our and our industries' future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors. These and other factors could cause our future performance to differ materially from our assumptions and estimates. As a result, you should be aware that market, ranking and other similar industry data included in this press release, and estimates and beliefs based on that data, may not be reliable.Media ContactAlan WallaceHead of Public Relationsmarketing@dvlt.ai+1.267.817.7251Investor ContactEdward BargerVP, Investor Relationsebarger@dvlt.aiFor more information on Datavault AI's RWA solutions or to schedule an interview with Nathaniel Bradley, contact the press team above.SOURCE: Datavault AI Inc Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo ACN Newswire

U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo

West Palm Beach, FL, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly supported the Division I National Intercollegiate Championship (NIC), held March 19-22, 2026, near Dallas, Texas, at the Prestonwood Polo & Country Club. As the highest level of collegiate polo in the United States, the NIC brings together the nation's top student-athletes to compete for national titles.2026 Division I Women's National Intercollegiate Champions, University of South Carolina - Aiken Polo Team Winifred Branscum, Madison Jordan, and Brianna Jordan; 2026 Division I Men's National Intercollegiate Champions, University of North Texas Polo Team Alec Felhaber, Niklaus Felhaber, Johann Felhaber, Mosiah Gravesande, Sebastian Celis GuerreroPhoto Credit: @oanaphotoAs a proud supporter of the USPA's Intercollegiate/Interscholastic (I/I) Program, U.S. Polo Assn. continues to invest in the next generation of polo players. For the 2026 NIC, the global sport brand provided custom event t-shirts for all participants, featuring special-edition designs honoring the 50th Anniversary of the Division I Women's NIC, along with player prizes for all finalists and exclusive U.S. Polo Assn. Champions Caps to the winning teams. On-site, the sport brand also enhanced the fan experience with cap giveaways, adding to the energy of the championship atmosphere.Division I Women's National Intercollegiate Championship at a Glance:Final Matchup: University of South Carolina - Aiken(Winifred Branscum, Brianna Jordan, Madison Jordan) vs. Texas A&M University(Josie Dorsey, Francesca Felhaber, Jordan Fikes, Alternates: Kylie Beard, Emily Coflin, Sophia DeAngelis)Date: March 22, 2026Location: Prestonwood Polo & Country Club, Oak Point, TexasFinal Score: 15 (USC-Aiken) - 6 (Texas A&M)All-Stars: Madison Jordan (USC-Aiken), Josie Dorsey (TAMU), Kelsey Bray (UVA), and Winifred Branscum (USC-Aiken)Best Playing Pony: Fiscal, played and owned by Winifred Branscum (USC-Aiken)Division I Men's National Intercollegiate Championship at a Glance:Final Matchup: University of North Texas(Alec Felhaber, Johann Felhaber, Niklaus Felhaber, Mosiah Gravesande, Alternate: Sebastian Celis Guerrero) vs. Cornell University(Benito Jarmillo, Malachi Light, Max Sponer, Alternates: Harrison Fredericks, Fin Maroney, Mihali Pinzon, Dylan Tung)Date: March 22, 2026Location: Prestonwood Polo & Country Club, Oak Point, TexasFinal Score: 15 (UNT) -13 (Cornell)All-Stars: Will Mudra (TAMU), Malachi Light (Cornell), Benito Jarmillo (Cornell), Johann Felhaber (UNT)Best Playing Pony: Zury, owned by Texas A&M UniversityU.S. Polo Assn. supports more than 30 colleges and universities and approximately 70 teams nationwide through its Collegiate Partnership Program (CPP). During its eighth consecutive year, the brand supports the next generation of polo players through jerseys, custom-performance apparel, branded equipment, financial contributions, and more. The CPP is available to all colleges and universities, with its participating teams ranging from the East to the West Coast and including small private and large public institutions, as well as Ivy League and Historically Black Colleges or Universities (HBCUs)."The Division I National Intercollegiate Championship represents the future of the sport, where dedication, teamwork, and passion for the sport of polo come together at the highest level of collegiate competition," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand. "U.S. Polo Assn. is proud to support these exceptional student-athletes and to continue investing in the next generation of players and future leaders at every level.""Congratulations to all of the participants in the Division I Women's and Men's Championships, and good luck to the Division II National Intercollegiate Championships participants next month," added Prince.The Division I Women's and Men's Finals will be featured on Global Polo's award-winning show, "Breakaway: Polo in College," and distributed across ESPN and Global Polo platforms, extending the reach of collegiate championship polo to a global audience. Check local listings for airtimes."The 2026 National Intercollegiate Championship marks the 50th Anniversary of the Division I Women's Intercollegiate Tournament, and it's inspiring to see the remarkable talent and commitment these student-athletes have shown throughout such a highly competitive and significant season," said Liz Brayboy, Chair of the USPA's Intercollegiate/Interscholastic (I/I) Committee. "With the continued support of U.S. Polo Assn., collegiate polo continues to grow and reach new audiences and sports fans, which is incredibly exciting for us, and collegiate sports overall."About U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sportsin India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth and sport content. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.For Additional Information, Contact:Shannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.comStacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comSOURCE: U.S. Polo Assn. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
Founders Metals Makes First Discovery at Antino North; Drills 17.22 g/t Au over 3.6 m within 24.6 m of 2.81 g/t Au ACN Newswire

Founders Metals Makes First Discovery at Antino North; Drills 17.22 g/t Au over 3.6 m within 24.6 m of 2.81 g/t Au

Vancouver, BC, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or the "Company") announces a new high-grade gold discovery at its Antino Gold Project ("Antino" or "Project") in southeastern Suriname. The Company reports high-grade gold mineralization from surface, returning 17.22 grams per tonne (g/t) gold (Au) over 3.6 metres (m) within a broader 24.6 m interval grading 2.81 g/t Au, in the first-ever drillhole in the Antino North area (Figure 1).HighlightsFirst ever Antino North drilling delivers exceptional results from surface in the first drillhole (AN001)24.6 m of 2.81 g/t Au including 3.60 m of 17.22 g/t Au from 1.5 m down hole13.5 m of 0.44 g/t Au from 54.6 mFirst drillhole testing one of twelve gold-bearing structures identified to date at Antino NorthSurface work continues:Over 4,500 auger samples to date in 2026Total combined strike length of mapped shear zones on surface is 5.3 kmSecond Antino North drill now turning on previously undrilled kilometre-scale gold auger anomaly (Figure 2)Colin Padget, President & CEO, commented, "The Antino North area covers nearly 10,000 hectares of highly prospective geology that has never seen a drillhole - so we are thrilled to see such high-grade results from our first diamond hole into the area. Our team on the ground has so far mapped twelve parallel shear zones across and along strike of the intercepted structure, and we plan to test many of them over the current ~3,500 metre phase-one drill program. This Antino North discovery reinforces our belief that the larger Antino Project is host to a major district-scale gold system, and there remains significant exploration upside and opportunity for further discoveries with this year's exploration program."Antino North DrillingThe new discovery is hosted within a series of approximately 5- to 25-metre-wide shear zones, with geological characteristics consistent with high-grade gold mineralization documented elsewhere on the Antino Gold Project, including at Upper Antino. The reported drillhole tested the first of twelve northwest-trending parallel shears recently mapped over multiple kilometres across the Antino North area, highlighting the significant scale of the mineralizing system. The mapped shear zones are spatially coincident with a large regional-scale fold - a structural setting commonly associated with orogenic gold deposits across the Guiana Shield.Mineralization is similar in character to the shear- and vein-hosted gold mineralization at Upper Antino, comprising sheared subvertical quartz veins with late brittle deformation overprinting and a sericite-ankerite-tourmaline alteration assemblage.The Antino North concession has no record of historical diamond drilling. This discovery represents the first drill-tested gold zone within the recently acquired exploration concession, located approximately 20 kilometres southwest of the Upper Antino area - confirming the potential for new mineralized centres across the district-scale Antino land package.Table 1: Drill Hole Assay ResultsDrillholeFrom (m)To (m)Interval (m)Au (g/t)AN0011.5026.1024.602.81incl1.505.103.6017.22and54.6068.1013.500.44 *Intervals are down-hole depths. True widths of mineralization are unknown at this time based on currently available results and observations. All are diamond drill holes. Interval average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher-grade gold intercepts. Widths are calculated using a 0.10 g/t gold cut-off grade with
Lebih lanjut
DENSO and FoodVentures Strengthen Collaboration through Capital Partnership in the Agricultural Sector JCN Newswire

DENSO and FoodVentures Strengthen Collaboration through Capital Partnership in the Agricultural Sector

KARIYA, JAPAN, Apr 2, 2026 - (JCN Newswire via SeaPRwire.com) - DENSO CORPORATION and FoodVentures announced that DENSO has acquired a partial equity stake in FoodVentures and made FoodVentures a consolidated subsidiary. Through this capital partnership, DENSO and FoodVentures will strengthen their collaboration to globally deploy the One-Stop Solution, which enables stable and predictable agricultural production through an integrated approach.In recent years, changes in social conditions—such as the progression of climate change, a declining farming population in some areas, and growing importance of food security—have accelerated efforts around the world to secure agricultural production and improve food self-sufficiency. As a result, new entrants into the agricultural sector are emerging, and there is a growing global demand to realize sustainably local-grown agricultural production.Since 2017, DENSO has positioned agriculture as a new pillar of its business and, in 2022, further strengthened this commitment by incorporating it into its articles of incorporation. Leveraging technologies developed through automotive component manufacturing—including production process design, sensing, and image processing—DENSO has been advancing environmental control and automation technologies for greenhouse horticulture.In addition, DENSO has been strengthening collaboration with partners that possesses expertise in greenhouses, seeds and seedlings, and cultivation technologies—key element for sustainable agricultural production. In 2023, DENSO welcomed Certhon, a provider of advanced horticultural greenhouses, into the DENSO Group. In 2025, DENSO also welcomed Axia, a developer and distributor of tomato seeds and seedlings, and entered into a joint development agreement with Delphy, a global cultivation consulting company.FoodVentures, newly joining the DENSO Group, has worked for more than 10 years to provide solutions that combine cultivation technologies with operational support, with a view to grow vegetables closer to its consumers. In recent years, FoodVentures has offered one-stop proposals to new entrants, covering everything from business planning to cultivation, farm operations, and crop sales, and has also provided services that undertake actual farm operations. FoodVentures has extensive expertise, and a proven track record built through supporting greenhouse horticulture operators in many countries across all climates.Going forward, through FoodVentures, the DENSO Group will offer integrated solutions of technology and know-how globally that maximize customer’s profitability. Through these efforts, DENSO will accelerate initiatives toward enabling stable and predictable agricultural production.DENSO CORPORATIONFood Value Chain Business UnitExecutive OfficerYasushi Mukai“In recent years, food growers have faced an increasing number of challenges, and agriculture is at a major turning point. By welcoming FoodVentures—which provides end-to-end support from business planning to cultivation, farm operations, and sales—into the DENSO Group, we have built a structure that enables us to deploy a One-Stop Solution globally that support the entire farming operation, beyond simply providing technology. Together with FoodVentures and our partners, we will work to realize the vision of providing safe, delicious, and environmentally friendly food anytime, anywhere, and for everyone.”FoodVentures B.V.CEODirk Aleven“After more than a decade of experience growing vegetables in greenhouses around the world, we see that projects are becoming larger and more complex. Exciting new opportunities are emerging, such as the use of residual heat from data centers and other co-location opportunities for greenhouses. These combinations enable safe, affordable, and fresh vegetable production close to consumers.”“We share DENSO CORPORATION’s ambition to offer a holistic solution to the horticultural industry by combining technology, data, and know-how. This new partnership creates an opportunity to unite technology, expertise, and scale to better meet the needs of our customers.”<Overview of FoodVentures> 1. Company Name FoodVentures B.V. 2. Established 2010 3. Head Office Europa 1, 2672 ZX Naaldwijk, The Netherlands 4. CEO Dirk Aleven 5. Revenue €2.9 million (2024) 6. Number of Employees 22 Representatives of both companies shaking handsFrom left: FoodVentures CEO Dirk Aleven,DENSO CORPORATION Executive Officer (Food Value Chain Business Unit) Yasushi Mukai About DENSO CORPORATIONDENSO is a global automotive parts manufacturer that provides advanced automotive technologies, systems, and products. Leveraging the technologies it has cultivated through automotive component development as its core strengths, DENSO is expanding the scope of its value offerings into areas such as factory automation, food distribution, and agriculture. Among these, DENSO positions agriculture as an important business domain in order to help realize stable and predictable production, which is essential to people’s daily lives. Going forward, DENSO will further strengthen the technologies and know-how required for cultivation and will work toward realizing sustainable agricultural production by providing optimal support to greenhouse horticulture operators around the world. https://www.denso.com/global/en/About FoodVentures B.V.FoodVentures is a global operator of greenhouses. It works with developers and investors to develop the right-tech solutions to grow vegetables near to its consumers, in a sustainable and cost-effective manner. The operators of FoodVentures support businesses with boots on the ground, and with the support of the expertise center in the Netherlands. With FoodVentures growers and tools it has proven to grow vegetables profitably in all various climates world-wide. FoodVentures wants to accelerate the success of CEA globally by supporting investors and business owners with their greenhouse operational knowledge and experience. https://foodventures.eu/ Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut
Luxury NEV Enterprise Seres Hits Record High Revenue of RMB164.89 Billion in 2025, Maintaining Positive Profitability for Second Consecutive Year ACN Newswire

Luxury NEV Enterprise Seres Hits Record High Revenue of RMB164.89 Billion in 2025, Maintaining Positive Profitability for Second Consecutive Year

HONG KONG, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Luxury new energy vehicle (NEV) enterprise Seres officially released its 2025 annual results on March 30, with several core financial indicators recording steady growth and profitability continuing to strengthen for the second consecutive year, attracting widespread market attention.The results report shows that in 2025, Seres achieved revenue of approximately RMB164.89 billion with a year-on-year increase of 13.63%, net profit attributable to shareholders of the listed company was RMB5.96 billion and R&D investment reached RMB12.51 billion, a year-on-year increase of 77.4%. The Company also announced a proposed final dividend of RMB0.8 per share (tax included), totaling approximately RMB1.9 billion in cash dividends, reflecting its commitment to rewarding shareholders.In terms of sales performance, Seres' NEV sales continued to maintain a high level. Annual sales in 2025 reached 472,269 units, representing a year-on-year increase of 10.63%. The Group's premium brand AITO recorded cumulative annual deliveries exceeding 420,000 units, making it the best-selling Chinese luxury automotive brand in the domestic market. Across the full lineup, the AITO M5, M7, M8, and M9 collectively surpassed one million cumulative deliveries. The coordinated growth in both sales and profit further strengthened the Group's overall operational resilience and risk management capabilities.In terms of R&D investment, Seres has maintained a strong commitment. In 2025, the Company’s R&D investment reached RMB12.51 billion, representing a year-on-year increase of 77.4%. Both the intensity and growth rate of R&D investment remained industry-leading, reflecting the Company’s adherence to a technology-driven strategy and laying a solid foundation for future product iteration and core competitiveness.The Group’s cash flow performance was also robust. As of December 31, 2025, net cash flow from operating activities amounted to RMB28.12 billion. Ample cash reserves enabled the Company to support high-intensity R&D and international expansion while building a stronger risk buffer and enhancing strategic flexibility.Kaiyuan Securities, Changjiang Securities, CICC, and Guotai Haitong are among the major brokerages maintaining positive ratings on Seres — Kaiyuan and Changjiang with "Buy," Guotai Haitong with "Overweight," and CICC with "Outperform" alongside a revised target price of RMB 120. All institutions are optimistic on Seres' long-term growth prospects, noting that underlying business fundamentals continue to improve with a clear and compelling growth thesis. Key catalysts include a dense Q2 model launch cycle (AITO M6 and refreshed M9/M8), accelerating overseas expansion into the Middle East and Europe, and a robotics business increasingly seen as a credible second growth curve.Overall, Seres delivered a comprehensive upgrade in its 2025 results, spanning sales volume, profit, R&D and cash flow. The Company stated that it will continue to position itself as a luxury vehicle enterprise, deepen its presence in the intelligent NEV sector, further increase investment in core technologies, enrich its high-end product portfolio, accelerate its global market expansion, and focus on improving profitability and core competitiveness, thereby supporting the continued upgrading of China’s new energy vehicle industry. For investors, this performance has undoubtedly strengthened confidence in the Company’s future growth. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
JRC, SKY Perfect JSAT, and Sharp Collaborate to Promote the Ministry of Defense’s Publicly Announced Project “Development and Demonstration of Resiliency Technology for Multi-Orbit Communications Systems” Selected for JRC JCN Newswire

JRC, SKY Perfect JSAT, and Sharp Collaborate to Promote the Ministry of Defense’s Publicly Announced Project “Development and Demonstration of Resiliency Technology for Multi-Orbit Communications Systems” Selected for JRC

TOKYO, Apr 2, 2026 - (JCN Newswire via SeaPRwire.com) - Japan Radio Co., Ltd. ("JRC"), SKY Perfect JSAT Corporation ("SKY Perfect JSAT"), and Sharp Corporation ("Sharp") will collaborate to develop and demonstrate a next-generation communications system in support of the Ministry of Defense (Japan) program titled "Development and Demonstration of Resilience-Enhancing Technologies for Multi-Orbit(1) Communications Systems", for which JRC was selected on February 4, 2026.This solicitation is intended to enhance the resilience(2) and reliability of communications infrastructure, in light of expanding communications demand in the disaster prevention and defense domains and the growing need to secure stable communications under a variety of circumstances, including natural disasters and unforeseen events. It aims to build a next-generation communications system that leverages a combination of GEO, MEO and LEO satellites(3), and to enable multi-orbit operation by establishing control technologies that allow seamless switching among satellite links—where satellite communications are currently operated through separate systems optimized for each orbit.During the project period through March 31, 2028, JRC will oversee overall project coordination, SKY Perfect JSAT will lead the development of a seamless communications network, and Sharp will primarily drive the development of a multi-orbit-capable satellite communications user terminal(4), as the three companies develop a communications system supporting multi-orbit operations across GEO, MEO and LEO satellites and validate improvements in communications network resilience.Through this demonstration, the three companies will strive to improve communications reliability under various conditions, including disasters and emergencies, and will contribute to maintaining critical social functions and ensuring safety and security.Outline of the Announcement Awarded to JRCOrdering PartyProject TitleProject DetailsImplementation PeriodThe successful bidder and cooperating companiesMinistry of DefenseDevelopment and Demonstration of Resiliency Technology for Multi-Orbit Communication Systems・Development and ground demonstration of a communication system compatible with multi-orbit and equipped with seamless switching functionality across communication links・Verification of the resiliency of communication infrastructure utilizing multi-orbit satellite communicationUntil March 31, 2028Japan Radio Co., Ltd.SKY Perfect JSAT CorporationSharp Corporation■ Company ProfilesCompany Name: Japan Radio Co., Ltd.Representative: Kaichiro Sakuma, Representative Director President and CEOHead Office: NAKANO CENTRAL PARK EAST,10-1, Nakano 4-chome, Nakano-ku, Tokyo 164-8570, JapanURL: https://www.jrc.co.jp/en/Company Name: SKY Perfect JSAT CorporationRepresentative: Eiichi Yonekura, Representative Director, President and CEOHead Office: Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo 107-0052, JapanURL: https://en.skyperfectjsat.space/Company Name: Sharp CorporationRepresentative: Tetsuji Kawamura, President and Executive Officer, CEOHead Office: 2-1-25 Kyutaromachi, Chuo-ku, Osaka-shi, Osaka 541-8522, JapanURL: https://global.sharp/(1) Multiple types of satellite orbits in which artificial satellites operate, such as geostationary, medium, and low Earth orbits.(2) The ability to maintain function and ensure stable use by providing alternative means or rapid recovery in the event of unexpected incidents.(3) Abbreviations for Geostationary Orbit, Medium Earth Orbit, and Low Earth Orbit.(4) A terminal integrating components such as a satellite communication antenna and modem functions. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut
MHIEC Completes Construction of Nanbu Relay Center for Nagasaki Prefecture’s Ken’ou-Kennan Clean Authority JCN Newswire

MHIEC Completes Construction of Nanbu Relay Center for Nagasaki Prefecture’s Ken’ou-Kennan Clean Authority

Nanbu Relay CenterTOKYO, Apr 2, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Environmental & Chemical Engineering Co., Ltd. (MHIEC), a part of Mitsubishi Heavy Industries (MHI) Group, has successfully completed the construction of the Nanbu Relay Center for the Ken'ou-Kennan Clean Authority (comprising the municipalities of Shimabara City, Isahaya City, Unzen City, and Minamishimabara City) in Nagasaki Prefecture. This project is part of the waste transfer facility development and operation contract awarded to MHIEC in 2024.The project involved establishing a new Nanbu Relay Center in Minamishimabara City and managing a total of three relay centers, including the existing Tobu and Seibu Relay Centers. This initiative supports the efficient and stable transportation of combustible waste generated throughout the member municipalities to the second-phase waste treatment facility, the Ken'ou-Kennan Clean Center, newly constructed in Isahaya City and scheduled to commence operations in April 2026.A relay center(Note1) serves as a critical hub where waste collected by refuse collection vehicles is compressed using compactors and transferred to large transport vehicles for delivery to incineration plants or final disposal sites. At the Nanbu Relay Center, approximately 43 tons of combustible waste per day are compressed and volume-reduced by using a compactor-container system before being transported to the Ken'ou-Kennan Clean Center.The total contract value for construction and operation of the facility amounts to approximately 11.375 billion yen (excluding tax). MHIEC, in joint venture with MHI Group's Jukan Operation Co., Ltd., has been entrusted with the 20-year operation and management of all three relay centers under a DBO(Note2) scheme.MHIEC took over the waste treatment plant business in 2008, acquiring MHI's technological development capabilities in environmental systems and broad-ranging expertise in the construction and operation of waste management facilities both in Japan and overseas. Based on this robust track record, MHIEC is well positioned to propose comprehensive solutions encompassing all aspects from plant construction to operation and maintenance. Beyond new facility development, MHIEC actively addresses after-sales services and DBO projects. Moving forward, the Company will continue to promote proposals aimed at energy conservation, advanced incinerator operations through AI and IoT-enabled remote monitoring and automated support, and lifecycle cost reduction, thereby expanding its footprint both domestically and internationally.(1) Relay centers are facilities where collected waste is compressed and transferred to larger transport vehicles for efficient delivery to incineration or disposal sites. For more details, please visit:https://www.mhi.com/jp/products/environment/wastes-transfer-facility.html(2) DBO stands for Design-Build-Operate. Under this scheme, public entities retain ownership of the facility while outsourcing its design, construction, and operation to private-sector partners.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut
Moving Beyond the ‘Blockbuster’ Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach: Dialogue with HighTide Therapeutics’ CMO Dr. Filip Surmont JCN Newswire

Moving Beyond the ‘Blockbuster’ Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach: Dialogue with HighTide Therapeutics’ CMO Dr. Filip Surmont

HONG KONG, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"—offering insights into a company's pipeline potential and reflecting how industry veterans gauge the sector’s future.A clear signal of the company’s growth arrived in February 2026, when HighTide Therapeutics (2511.HK) announced a high-profile executive appointment: Dr. Filip Surmont joined the company as Chief Medical Officer (CMO).For professionals in the cardiovascular, renal, and metabolic fields, this is a name that carries real weight. Over a career spanning three decades, Dr. Surmont has held senior medical leadership roles at multinational giants including Wyeth, Pfizer, and AstraZeneca. Among his most notable contributions was his role in the global strategic development of the SGLT-2 inhibitor dapagliflozin — a landmark effort that required close collaboration across functions and geographies within a large multinational organization. As part of a talented cross-functional team, he helped shape the strategy that positioned dapagliflozin as a global metabolic blockbuster, ultimately reaching $8.405 billion USD in sales in 2025.Notably, just a few months earlier, HighTide Therapeutics' core product, HTD1801, had outperformed dapagliflozin across multiple key cardiovascular, renal, and metabolic endpoints in a head-to-head Phase III clinical trial for type 2 diabetes mellitus (T2DM).For Dr. Surmont, transitioning from managing a reigning "blockbuster" to joining a “challenger” Chinese biotech was far from coincidental. What drew him out of his comfort zone was not just HTD1801's strong glucose-lowering performance, but also the breakthrough potential this new molecular entity (NME) has shown in cardiovascular, kidney and metabolic (CKM) disease in general, and chronic kidney disease (CKD) more specifically — driven by a fundamentally differentiated pathophysiological mechanisms.I.Challenging Clinical Complacency in CKD: The Quest for True ReversalWithin the medical community, chronic kidney disease (CKD) has long been a source of frustration. Once the kidney function begins to decline, it typically deteriorates progressively and irreversibly over time, leaving most patients facing dialysis or kidney transplantation as an eventual outcome."There has long been a degree of complacency in CKD treatment among physicians, patients, and even caregivers," Dr. Surmont noted pointedly. "A mindset has taken hold that the progressive decline in renal function with age is inevitable. I’ve been striving to change this mindset throughout my career, both during my time at multinational pharmaceutical companies and now."Current standard treatments — including ACE inhibitors/ARBs and the widely used SGLT-2 inhibitors — have demonstrated efficacy in slowing disease progression, yet fall short of halting or reversing the underlying pathology. They can significantly reduce the rate of decline in the estimated glomerular filtration rate (eGFR), buying patients valuable time, but fail to alter the terminal trajectory towards kidney failure.Further complicating the clinical picture is the multi-factorial nature of CKD. Taking diabetic kidney disease (DKD) caused by T2DM as an example, besides pathophysiological factors driven by metabolic dysfunction, it is complicated by interconnected and highly complex factors such as hemodynamic perturbances, chronic inflammation, fibrosis, and other non-diabetic factors that fuel each other to worsen disease prognosis.Existing standard-of-care drugs often address only one dimension of the disease by regulating hemodynamics or a single metabolic pathway, making it difficult to comprehensively address the inflammatory damage in the renal microenvironment.II.Inside the Mechanism: Remodeling Renal Architecture via a Dual Metabolic and Anti-inflammatory PathwayThe emergence of HTD1801 provides a new key to breaking this deadlock.As an oral anti-inflammatory and metabolic modulator (AIMM) independently developed by HighTide Therapeutics, HTD1801 demonstrates a unique therapeutic potential at the microscopic level as compared to traditional drugs. Rather than relying on a single mechanism, it takes a "two-pronged" approach by activating AMPK (adenosine monophosphate-activated protein kinase) and inhibiting the NLRP3 inflammasome.Dr. Surmont has full confidence in the scientific logic underpinning this mechanism: "This drug acts simultaneously on two critical levels: beyond blood sugar, it improves overall metabolic efficiency at its source; at the same time, it directly suppresses the underlying chronic inflammation that drives organ damage."Taking a deep dive into its mechanism of action, HTD1801's dual mechanism precisely targets multiple microstructures within the kidney. "This is reflected across different renal compartments," Dr. Surmont explained. "From the filtering glomeruli and the structural interstitium to the reabsorptive tubules, and even podocytes—the vital gatekeepers of the filtration barrier, the dual action of AMPK activation and NLRP3 inhibition has demonstrated stronger-than-expected protective benefits."This mechanistic rationale, spanning from metabolic regulation to organ-level protection, has ultimately been validated by clinical data.At the 2025 American Society of Nephrology (ASN) Annual Meeting, HighTide Therapeutics presented as a late breaker Phase III clinical study data in T2DM patients with mild renal impairment. The results captured the industry's attention: compared with the placebo group, the HTD1801 group demonstrated a significant and sustainable difference in annualized eGFR slope of +9.81 ml/min/1.73 m²/year.In the eyes of nephrologists, a "positive slope" on the eGFR curve is a strong and unique signal, suggesting the possibility of early structural recovery."What we need to do next is confirm that this eGFR repair effect observed in DKD also holds true for CKD patients not driven by diabetes," Dr. Surmont revealed, indicating that relevant clinical studies are already underway, with more detailed data expected to validate this cross-etiology therapeutic potential.III.From "Rescue" to "Prevention": Advancing a Holistic Cardiorenal Metabolic (CKM) MindsetDr. Surmont brings to HighTide Therapeutics more than just clinical expertise; he brings a “game-changing” mentality that transcends a single-drug perspective.Another career-defining milestone for Dr. Surmont was his leadership role in helping reshape global asthma treatment guidelines. Historically, asthma management relied on short-acting bronchodilators for "rescue" only upon exacerbation of symptoms and shortness of breath. Dr. Surmont proposed and validated the "Anti-Inflammatory Reliever (AIR)" strategy a modern asthma management strategy that uses a combination inhaled corticosteroids and a bronchodilator as a reliever — treating both the acute bronchospasm and the underlying airway inflammation with every dose, in contrast to traditional short acting dilator-only relief. This shift ultimately benefited approximately 120 million patients worldwide and reshaped treatment paradigms.Now, facing CKD, he sees the same opportunity for a paradigm-shifting breakthrough.Given HTD1801's strong potential to repair mild renal impairment, future clinical guidelines could reasonably recommend initiating treatments early, when eGFR is still at a relatively high level. By establishing a positive trajectory for renal function recovery early in the disease, there is hope that most patients can completely avoid the looming threat of dialysis.From a health-economics perspective, this would reallocate healthcare spending: shifting funds away from costly late-stage interventions (such as dialysis and heart failure rescue) towards highly cost-effective early treatment, thereby generating substantial healthcare cost savings for society and reducing patients’ financial burden for late-stage interventions.Dr. Surmont also strongly advocates for a holistic management approach to "Cardiovascular-Kidney-Metabolic (CKM)" health. As multifunctional drugs like HTD1801 continue to evolve, he believes physicians will move beyond the single-dimensional therapeutic mindset."My ideal scenario is that all physicians managing cardiovascular, metabolic, renal, hepatic, or even obesity issues would evaluate the patient with a holistic mindset," he says, pointing to the current siloed nature in clinical practice. " As an example eGFR monitoring is not always part of routine cardiological assessment, yet at the mechanistic level, cardiac and renal dysfunction are manifestations of the same underlying disease process — making an integrated view essential"He cited a successful experiment he led while promoting dapagliflozin in China: requiring cardiologists at partner hospitals to measure patients' eGFR during their consultations. By merely adding this simple cross-disciplinary action, the number of patients on guideline directed medical treatment tripled within six months.IV.A Buyer's Lens: The Booming BD Activity in CKD and HighTide Therapeutics’ Confidence in Value CreationAs a core member of the company's leadership team, Dr. Surmont also frequently examines HighTide Therapeutics' position through the lens of capital market and industry dynamics.Over the past two years, the global biopharmaceutical market has seen a surge in business development (BD) activity in the CKD field. In 2025, Roche announced a major collaboration with Zealand Pharma valued at up to $5.3 billion; multinational giants like Novartis, Boehringer Ingelheim, and Novo Nordisk have also been making significant investments to secure premium assets in the metabolic and renal disease space.Dr. Surmont, drawing on his extensive multinational experience, has a clear read on this "land grab" phenomenon: "The core driver is the massive profit potential and rapid growth in this field. Five years ago, the therapeutic arsenal here was relatively limited. Now, with breakthrough blockbusters like GLP-1RAs and SGLT-2i’s, the kidney disease landscape has been reshaped, yet there remains a residual risk is 60–80% of the original event burden.He further elaborated: "Even when patients are treated with four pillars of therapy (ACEi/ARBs, SGLT-2i’s, GLP-1RAs, MRAs), the complex underlying inflammatory mechanisms remain largely unaddressed, still leaving a significant gap in our ability to fully protect the kidney. This creates substantial pricing potential and broad combination therapy prospects for drugs with fundamentally new mechanisms like HTD1801.""Looking back at the history of SGLT-2 inhibitors, it took over a decade from approval to reaching 20%-25% guideline-directed clinical uptake. The slow progress was partly due to a lack of strong medical education and advocacy, and partly because of physicians and patients’ tendency to yield to the disease's natural trajectory."Now, having taken the helm as CMO of HighTide Therapeutics, Dr. Filip Surmont is poised to challenge the status quo and break this complacency with solid clinical data and a new medical narrative. For this drug—born from Chinese innovation with a global ambition—the voyage in the CKM field has only just begun. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut
Dialogue with HighTide Therapeutics’ CMO Dr. Filip Surmont: Moving Beyond the “Blockbuster” Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach ACN Newswire

Dialogue with HighTide Therapeutics’ CMO Dr. Filip Surmont: Moving Beyond the “Blockbuster” Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach

HONG KONG, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"—offering insights into a company's pipeline potential and reflecting how industry veterans gauge the sector’s future.A clear signal of the company’s growth arrived in February 2026, when HighTide Therapeutics (2511.HK) announced a high-profile executive appointment: Dr. Filip Surmont joined the company as Chief Medical Officer (CMO).For professionals in the cardiovascular, renal, and metabolic fields, this is a name that carries real weight. Over a career spanning three decades, Dr. Surmont has held senior medical leadership roles at multinational giants including Wyeth, Pfizer, and AstraZeneca. Among his most notable contributions was his role in the global strategic development of the SGLT-2 inhibitor dapagliflozin — a landmark effort that required close collaboration across functions and geographies within a large multinational organization. As part of a talented cross-functional team, he helped shape the strategy that positioned dapagliflozin as a global metabolic blockbuster, ultimately reaching $8.405 billion USD in sales in 2025.Notably, just a few months earlier, HighTide Therapeutics' core product, HTD1801, had outperformed dapagliflozin across multiple key cardiovascular, renal, and metabolic endpoints in a head-to-head Phase III clinical trial for type 2 diabetes mellitus (T2DM).For Dr. Surmont, transitioning from managing a reigning "blockbuster" to joining a “challenger” Chinese biotech was far from coincidental. What drew him out of his comfort zone was not just HTD1801's strong glucose-lowering performance, but also the breakthrough potential this new molecular entity (NME) has shown in cardiovascular, kidney and metabolic (CKM) disease in general, and chronic kidney disease (CKD) more specifically — driven by a fundamentally differentiated pathophysiological mechanisms.I.Challenging Clinical Complacency in CKD: The Quest for True ReversalWithin the medical community, chronic kidney disease (CKD) has long been a source of frustration. Once the kidney function begins to decline, it typically deteriorates progressively and irreversibly over time, leaving most patients facing dialysis or kidney transplantation as an eventual outcome."There has long been a degree of complacency in CKD treatment among physicians, patients, and even caregivers," Dr. Surmont noted pointedly. "A mindset has taken hold that the progressive decline in renal function with age is inevitable. I’ve been striving to change this mindset throughout my career, both during my time at multinational pharmaceutical companies and now."Current standard treatments — including ACE inhibitors/ARBs and the widely used SGLT-2 inhibitors — have demonstrated efficacy in slowing disease progression, yet fall short of halting or reversing the underlying pathology. They can significantly reduce the rate of decline in the estimated glomerular filtration rate (eGFR), buying patients valuable time, but fail to alter the terminal trajectory towards kidney failure.Further complicating the clinical picture is the multi-factorial nature of CKD. Taking diabetic kidney disease (DKD) caused by T2DM as an example, besides pathophysiological factors driven by metabolic dysfunction, it is complicated by interconnected and highly complex factors such as hemodynamic perturbances, chronic inflammation, fibrosis, and other non-diabetic factors that fuel each other to worsen disease prognosis.Existing standard-of-care drugs often address only one dimension of the disease by regulating hemodynamics or a single metabolic pathway, making it difficult to comprehensively address the inflammatory damage in the renal microenvironment.II.Inside the Mechanism: Remodeling Renal Architecture via a Dual Metabolic and Anti-inflammatory PathwayThe emergence of HTD1801 provides a new key to breaking this deadlock.As an oral anti-inflammatory and metabolic modulator (AIMM) independently developed by HighTide Therapeutics, HTD1801 demonstrates a unique therapeutic potential at the microscopic level as compared to traditional drugs. Rather than relying on a single mechanism, it takes a "two-pronged" approach by activating AMPK (adenosine monophosphate-activated protein kinase) and inhibiting the NLRP3 inflammasome.Dr. Surmont has full confidence in the scientific logic underpinning this mechanism: "This drug acts simultaneously on two critical levels: beyond blood sugar, it improves overall metabolic efficiency at its source; at the same time, it directly suppresses the underlying chronic inflammation that drives organ damage."Taking a deep dive into its mechanism of action, HTD1801's dual mechanism precisely targets multiple microstructures within the kidney. "This is reflected across different renal compartments," Dr. Surmont explained. "From the filtering glomeruli and the structural interstitium to the reabsorptive tubules, and even podocytes—the vital gatekeepers of the filtration barrier, the dual action of AMPK activation and NLRP3 inhibition has demonstrated stronger-than-expected protective benefits."This mechanistic rationale, spanning from metabolic regulation to organ-level protection, has ultimately been validated by clinical data.At the 2025 American Society of Nephrology (ASN) Annual Meeting, HighTide Therapeutics presented as a late breaker Phase III clinical study data in T2DM patients with mild renal impairment. The results captured the industry's attention: compared with the placebo group, the HTD1801 group demonstrated a significant and sustainable difference in annualized eGFR slope of +9.81 ml/min/1.73 m²/year.In the eyes of nephrologists, a "positive slope" on the eGFR curve is a strong and unique signal, suggesting the possibility of early structural recovery."What we need to do next is confirm that this eGFR repair effect observed in DKD also holds true for CKD patients not driven by diabetes," Dr. Surmont revealed, indicating that relevant clinical studies are already underway, with more detailed data expected to validate this cross-etiology therapeutic potential.III.From "Rescue" to "Prevention": Advancing a Holistic Cardiorenal Metabolic (CKM) MindsetDr. Surmont brings to HighTide Therapeutics more than just clinical expertise; he brings a “game-changing” mentality that transcends a single-drug perspective.Another career-defining milestone for Dr. Surmont was his leadership role in helping reshape global asthma treatment guidelines. Historically, asthma management relied on short-acting bronchodilators for "rescue" only upon exacerbation of symptoms and shortness of breath. Dr. Surmont proposed and validated the "Anti-Inflammatory Reliever (AIR)" strategy a modern asthma management strategy that uses a combination inhaled corticosteroids and a bronchodilator as a reliever — treating both the acute bronchospasm and the underlying airway inflammation with every dose, in contrast to traditional short acting dilator-only relief. This shift ultimately benefited approximately 120 million patients worldwide and reshaped treatment paradigms.Now, facing CKD, he sees the same opportunity for a paradigm-shifting breakthrough.Given HTD1801's strong potential to repair mild renal impairment, future clinical guidelines could reasonably recommend initiating treatments early, when eGFR is still at a relatively high level. By establishing a positive trajectory for renal function recovery early in the disease, there is hope that most patients can completely avoid the looming threat of dialysis.From a health-economics perspective, this would reallocate healthcare spending: shifting funds away from costly late-stage interventions (such as dialysis and heart failure rescue) towards highly cost-effective early treatment, thereby generating substantial healthcare cost savings for society and reducing patients’ financial burden for late-stage interventions.Dr. Surmont also strongly advocates for a holistic management approach to "Cardiovascular-Kidney-Metabolic (CKM)" health. As multifunctional drugs like HTD1801 continue to evolve, he believes physicians will move beyond the single-dimensional therapeutic mindset."My ideal scenario is that all physicians managing cardiovascular, metabolic, renal, hepatic, or even obesity issues would evaluate the patient with a holistic mindset," he says, pointing to the current siloed nature in clinical practice. " As an example eGFR monitoring is not always part of routine cardiological assessment, yet at the mechanistic level, cardiac and renal dysfunction are manifestations of the same underlying disease process — making an integrated view essential"He cited a successful experiment he led while promoting dapagliflozin in China: requiring cardiologists at partner hospitals to measure patients' eGFR during their consultations. By merely adding this simple cross-disciplinary action, the number of patients on guideline directed medical treatment tripled within six months.IV.A Buyer's Lens: The Booming BD Activity in CKD and HighTide Therapeutics’ Confidence in Value CreationAs a core member of the company's leadership team, Dr. Surmont also frequently examines HighTide Therapeutics' position through the lens of capital market and industry dynamics.Over the past two years, the global biopharmaceutical market has seen a surge in business development (BD) activity in the CKD field. In 2025, Roche announced a major collaboration with Zealand Pharma valued at up to $5.3 billion; multinational giants like Novartis, Boehringer Ingelheim, and Novo Nordisk have also been making significant investments to secure premium assets in the metabolic and renal disease space.Dr. Surmont, drawing on his extensive multinational experience, has a clear read on this "land grab" phenomenon: "The core driver is the massive profit potential and rapid growth in this field. Five years ago, the therapeutic arsenal here was relatively limited. Now, with breakthrough blockbusters like GLP-1RAs and SGLT-2i’s, the kidney disease landscape has been reshaped, yet there remains a residual risk is 60–80% of the original event burden.He further elaborated: "Even when patients are treated with four pillars of therapy (ACEi/ARBs, SGLT-2i’s, GLP-1RAs, MRAs), the complex underlying inflammatory mechanisms remain largely unaddressed, still leaving a significant gap in our ability to fully protect the kidney. This creates substantial pricing potential and broad combination therapy prospects for drugs with fundamentally new mechanisms like HTD1801.""Looking back at the history of SGLT-2 inhibitors, it took over a decade from approval to reaching 20%-25% guideline-directed clinical uptake. The slow progress was partly due to a lack of strong medical education and advocacy, and partly because of physicians and patients’ tendency to yield to the disease's natural trajectory."Now, having taken the helm as CMO of HighTide Therapeutics, Dr. Filip Surmont is poised to challenge the status quo and break this complacency with solid clinical data and a new medical narrative. For this drug—born from Chinese innovation with a global ambition—the voyage in the CKM field has only just begun. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut

AIoT Smart Healthcare Megatrend Arrives Home Control Powers a New Family Health Ecosystem with a ‘Smart Home + Health & Wellness’ Dual-Engine Strategy

EQS via SeaPRwire.com / 02/04/2026 / 10:58 UTC+8 As global population aging intensifies and consumers place greater emphasis on health management in the post-pandemic era, the convergence of AIoT with healthcare has emerged as a core pillar of the next technological wave. In this blue-ocean market, poised to surpass the trillion-dollar mark, the key question lies in extending professional medical services from hospitals into home, a critical focus for the industry. Against this backdrop, Home Control International Limited (1747.HK), a leading global provider of home control solutions, is executing a forward-looking strategic transformation. While continuing to deepen its core home control business, the Group has upgraded its brand to the "Omni Devices" brand, further expanding into the healthcare sector. Home Control is not merely following a trend; it is actively reshaping the global health management value chain through its deep technological expertise. The Company's latest 2025 annual results underscore its solid growth trajectory. Full-year revenue reached approximately US$109.4 million, representing a year-on-year increase of 1.8%, demonstrating operational resilience amidst a challenging macroeconomic environment. Regionally, while maintaining a strong presence in the Europe and the U.S. (which together accounted for approximately 70.2% of total revenue), the Company is strategically expanding into high-growth emerging markets, particularly India. Notably, revenue contribution from Asia increased from 13.0% in 2024 to 24.5% in 2025. This strategic shift not only optimizes the product mix but also provides diversified momentum for the Group's future growth. Driven by strong growth in higher-margin healthcare solutions and the absence of last year’s one-off impairment provision, profit attributable to owners of the Company surged 183.3% year-on-year to US$7.1 million. Rapid Smart Home Adoption in Europe and the U.S., as Whole-Home Automation Gains Momentum The global smart home market is expanding rapidly. According to Global Market Insights, the European smart home market is projected to grow at a CAGR of 16.1% between 2026 and 2035, reaching US$150.1 billion by 2035. Meanwhile, North America, the world's largest and most mature market, accounts for nearly 40% of global growth and is rapidly shifting from standalone devices to whole-home automation. This trend is driven by two key factors. First, strong consumer demand for home security is accelerating the adoption of integrated smart security and mobile applications. Second, rising energy costs and stricter energy-efficiency regulations are significantly boosting demand for smart thermostats and lighting systems. Leveraging its extensive experience in high-quality home control solutions, Home Control upgraded its "Omni Remotes" brand to "Omni Devices" at the end of 2024. This strategic rebranding reflects the Company's evolution beyond traditional control solutions into a broader spectrum of offerings. By applying its long-established expertise in technology innovation, particularly in advanced sensing and wireless connectivity, the Company is developing tailored solutions for vertical segments, unlocking new growth drivers in the flourishing smart home market. Asia-Pacific Digital Health to Reach US$713 Billion, Strategically Targeting the Home Health Monitoring Megatrend In contrast, the Asia-Pacific region is demonstrating even stronger momentum in the digital health. Market forecasts project the sector to grow at a CAGR of 22.98% from 2025 to 2035, surpassing US$713 billion. Remote patient monitoring and telehealth are among the fastest-growing segments, driven by the accelerating aging population across Asia and the increasing prevalence of chronic diseases like diabetes and cardiovascular conditions. These trends are significantly boosting demand for home-based health monitoring devices—such as blood glucose and blood pressure monitors—as well as preventive care solutions. Simultaneously, high smartphone penetration rates and strong government support for digital health infrastructure (e.g., China's "Healthy China 2030" policy) are accelerating the adoption of medical-grade devices in the home. In 2025, Home Control broadened its presence in the healthcare sector by integrating resources with its shareholder, Meta-Wisdom Tech Limited. During the year, revenue from healthcare solutions increased from 14.4% in 2024 to 21.4% of total revenue, highlighting the initial success of its transformation strategy. To build on this momentum, the Company established Orbiva Limited, a wholly-owned subsidiary in Hong Kong, dedicated to developing AIoT-enabled home healthcare platforms, ecosystems, and health management products. On the technology front, the Group has signed a strategic memorandum of understanding (MOU) with Nanyang Technological University (NTU) to jointly develop a secure AIoT-powered healthcare platform. Additionally, Orbiva has secured an intellectual property license for an AI assisted trustworthy home-care intelligence agent system, actively promoting the development of digital twin applications and secure health management devices. By combining technology R&D, data security, and product innovation, Home Control is accelerating the development of an integrated health management solution encompassing "Devices + Platform + Services," while deepening its presence in the Southeast Asian market to capitalize on regional growth opportunities. Smart IoT Empowers Personal Health Management, Launching a Closed-Loop Ecosystem and Transforming Valuation Overall, Home Control is undergoing a profound strategic transformation. While leveraging its established smart home foundation to generate stable cash flow, the Group has also been rapidly expanding its high-growth, high-value healthcare business. Building on this foundation, the Company is constructing a comprehensive ecosystem spanning hardware, software, data, and services through strategic acquisitions, industry-academia collaborations, and diverse partnerships. As the convergence of AIoT and healthcare deepens, the Group is steadily advancing toward its goal of real-time personal health monitoring and seamless integration of online-offline healthcare management. It is also accelerating the deep integration of smart home and health & wellness scenarios. This transformation not only provides a clear and scalable path for future growth but is also expected to drive long-term value creation and a sustained re-rating of the Company's valuation. 02/04/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
Lebih lanjut
Mazda EZ-6/Mazda6e Wins 2026 World Car Design of the Year Award JCN Newswire

Mazda EZ-6/Mazda6e Wins 2026 World Car Design of the Year Award

HIROSHIMA, Japan, Apr 2, 2026 - (JCN Newswire via SeaPRwire.com) - At the 2026 World Car of the Year Awards hosted by the World Car Awards (WCA), Mazda EZ-6/Mazda6e from Mazda Motor Corporation (Mazda) won the 2026 World Car Design of the Year (WCDOTY), one of the special awards. This marks the third time a Mazda model has earned this award, following the Mazda Roadster (known overseas as the Mazda MX-5) in 2016 and the Mazda3 in 2020.The awards were officially launched in January 2004 with automotive journalists around the world. For the 2026 award, the winner was selected from ninety eligible models through votes cast by 98 automotive journalists worldwide. The final results were announced by the World Car Awards (WCA) on April 1st local time in New York, USA.MAZDA 6e (European specification model)The Mazda EZ-6/Mazda6e represents a new challenge in Mazda’s journey toward electrification, pursuing both preservation and innovation of the distinctive design that Mazda has cultivated over the years. Under Mazda’s design theme, “KODO — Soul of Motion,” and based on the concept of “Authentic Modern,” the model combines vibrant, life-inspired forms with a sense of advanced modernity befitting a battery electric vehicle (BEV), while achieving a beautifully proportioned coupe silhouette. Through sculptural forms and meticulous craftsmanship created by the human hand, Mazda has delivered a design that continues to offer the joy of driving and moving mobility experience even in the era of electrification.The Mazda EZ-6 is a BEV launched in China in October 2024. It combines Mazda’s signature design and Jinba-ittai driving performance – the oneness between man and machine - with the electric and smart technologies of its collaborative partner*1 . The Mazda6e was developed based on the Mazda EZ-6 with further refinement to meet the driving performance and functionality needs of each market. It went on sale in Europe in September 2025, and plans are in place to introduce the model also in Australia, ASEAN, and other regions in 2026 as Mazda intends to respond to the growing demand for BEV in these markets.Mazda will continue to pursue the “Joy of Driving” under its core value of “Radically Human,” and aim to deliver the “Joy of Living” by creating moving mobility experiences in our customers' daily lives.*1 Chongqing Changan Automobile Co., Ltd. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut
TransNusa Strengthens Domestic Network Connection with New Route Launch and Increased Scheduled Flight Frequency ACN Newswire

TransNusa Strengthens Domestic Network Connection with New Route Launch and Increased Scheduled Flight Frequency

TransNusa Launches New Scheduled Flight Connecting Jakarta With Lombok, Its World Class Surfing Island DestinationJAKARTA, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - TransNusa has announced the launch of a new direct scheduled flight connecting Jakarta and Lombok, further strengthening access to one of Indonesia’s key tourism and regional travel hubs.TransNusa Airlines Group Chief Executive Officer, Datuk Bernard Francis said that the introduction of this new route comes on the back of the airline’s focus to increase and strengthen connectivity while boosting domestic tourism.“Lombok is not only rapidly growing as a domestic and international tourist destination but the island is also the main gateway for tourism in the West Nusa Tenggara region through its Lombok International Airport,” Datuk Francis said, adding that Lombok attracts more than 1.2 million tourists annually.LOMBOK… Paradise of divers and surfersLombok is home to the diving haven Gili and Mount Rinjani National Park, one of Indonesia’s most iconic volcanic landscapes. The island offers dramatic trekking routes, cascading waterfalls and panoramic mountain views, attracting adventurers and nature lovers from around the world. Beyond its mountains, Lombok has also built a global reputation as a world-class surfing and diving destination, with pristine beaches, coral reef and consistent waves drawing surfers year-round.“TransNusa will initially operate 14 flights a week or two daily flights with the first scheduled flight departing Jakarta in the morning and the second in the afternoon,” Datuk Bernard said, adding that the sales of tickets for the new scheduled flight from Jakarta to Lombok started on 16 March 2026, with the inaugural flight scheduled for April 17, 2026.DATUK BERNARD FRANCIS… Lombok is the main gateway for tourism in the West Nusa Tenggara regionIn addition to this new launch, TransNusa has also increased the frequency of its Jakarta-Yogyakarta route with the aim to enhance and strengthen domestic connectivity, said Datuk Bernard.Flight DetailsTransNusa’s scheduled flight 8B 5161 will depart Soekarno–Hatta International Airport at 5:00am and arrive at Lombok International Airport at 8:00am. The returning service, 8B 5162, will depart Lombok International Airport at 8:30am and arrive in Jakarta at the Soekarno–Hatta International Airport at 9:30am. The second scheduled flight 8B 5165 will depart Jakarta’s Soekarno–Hatta International Airport at 03:00pm and arrive at the Lombok International Airport at 05:45pm. The returning service, 8B 5166 will depart Lombok International Airport at 06.15pm and arrive at the Soekarno–Hatta International Airport at 06.45pm.Ticket prices for TransNusa’s scheduled Jakarta-Lombok route start from as low as IDR899,000, CNY390, USD55, MYR225, AUD80, and SGD69. Tickets will be available for purchase at www.transnusa.co.id and on primary online travel agents’ platforms.Meanwhile, TransNusa’s additional scheduled flight for its Jakarta-Yogyakarta flight, 8B 5530, will depart Jakarta’s Soekarno–Hatta International Airport at 10.40am and arrive at the Yogyakarta International Airport at 11.50am. The flight, 8B 5531, will depart Yogyakarta at 01.20pm and arrive in Jakarta at 02.30pm.For its flights, TransNusa not only provides premium services with competitive ticket prices, but the airline also has attractive product bundles called SEAT, SEAT-PLUS and FLEXI-PRO."Our SEAT passengers will enjoy check-in baggage of up to 20kgs,” Datuk Bernard said, explaining that the baggage offering was over and above the 7kgs limit offered as a passenger’s hand carry.For the highest package, FLEXI-PRO, we provide services such as free baggage up to 30kgs, free to choose seats, free food, and drinks, priority at check-in and boarding counters.In addition, TransNusa also provides its FLEXI-PRO passengers with the flexibility to change their flight schedule without restrictions and obtain refund when needed,” added Datuk Bernard.TransNusa, which aims to ensure its passengers travel with ease and comfort, has also configured their A320s with a 174-seat configuration, which allows for passengers to enjoy about 30 inches of legroom, comparable to the experience passengers would get in a full-service airline."We are committed to providing affordable and competitive ticket prices, while still providing premium services to our customers.” stressed Datuk Bernard.TransNusa, A Short HistoryThe 3-year old TransNusa, led by aviation expert and veteran, Datuk Bernard, made waves in the aviation industry with its unique domestic and international business development and growth strategy.Within just 6 months of operations, in 2023, the airline, known then as a new player with new rules, launched its first international route between Jakarta and Kuala Lumpur, followed by the launch of scheduled flights between Jakarta and Singapore.TransNusa, which established itself as a Premium Service Carrier, made headlines in Malaysia, Singapore, China and around the world with news of being the first airline in Indonesia to introduce new exciting routes. In 2023, during its first year of operations, TransNusa became the second Indonesian airline to receive approval to fly to China. In 2024, TransNusa became the first in the world to develop and introduce a new domestic route connecting Bali and Manado. In October 2025, TransNusa added yet another milestones by becoming the first Indonesian airline and second airline in the world to launch scheduled flights from Manado to Guangzhou, China.About TransNusaTransNusa Airline, is a Premium Service Carrier. In February 2024, the airline rebranded itself to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered. TransNusa, which received its AOC certification on 9th September 2022, launch its first three A320 operations on 6th October, 14th October and 12th December, 2022.In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently based in Jakarta and Bali.On the international front, TransNusa flies to Singapore, Guangzhou, Kuala Lumpur, Perth, Shanghai, and Shenzhen. The airline became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model. Passengers can book their flights on the TransNusa website at www.transnusa.co.id, through any secure online travel agent, through authorized travel agents in Singapore and Indonesia.TransNusa’s Primary International Media Contact:Trina Thomas Rajtrina@myqaseh.org+60124992672 (whatsapp only) Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
RMB 2 Billion Investment Leverages Approximately RMB 8 Billion in Book Value Gains: Shoucheng Holdings (0697.HK) Enters the Monetization Phase of Its Robotics Investments ACN Newswire

RMB 2 Billion Investment Leverages Approximately RMB 8 Billion in Book Value Gains: Shoucheng Holdings (0697.HK) Enters the Monetization Phase of Its Robotics Investments

HONG KONG, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Shoucheng Holdings’ (0697.HK) investments in the robotics sector are moving from early-stage positioning toward value realization.Management has disclosed that, by the end of 2025, the Company—through multiple industry funds under its management—had cumulatively invested more than RMB 2 billion across the broader robotics industry chain, covering more than 20 companies. According to the Chairman’s Statement for 2025, the valuation of the investment portfolio of the Beijing Robot Industry Development Investment Fund (Limited Partnership) increased by approximately fourfold. On that basis, the corresponding unrealized book gain is estimated at around RMB 8 billion. The robotics business has therefore become one of the most closely watched sources of incremental upside for Shoucheng Holdings in the near term.Based on disclosed projects, Shoucheng Holdings’ robotics strategy is not a series of isolated bets, but rather a systematic deployment across the industry chain. In the field of embodied intelligence and robotics, the Company has made concentrated investments in more than 20 leading companies, including Unitree Robotics, Noetix Robotics, Galbot, DEEP Robotics, Booster Robotics, and Galaxea AI. In the latest Chairman’s Statement, Chairman Zhao Tianyang characterized this approach as “track-level deployment”.Unlike some purely financial investors, Shoucheng Holdings is advancing its robotics business from simply “holding equity stakes” to “operating an industry”. Following an integrated path of “investment + operations + ecosystem,” the Company is building capabilities centered on “funds + scenarios + industry chain,” providing robotics companies with capital support, application scenarios, supply-chain integration, and commercialization pathways. On the offline channel side, its robotics consumer experience brand, Taozhu New Creation, has established five stores in Beijing, with locations including Shougang Park, Beijing Capital International Airport Terminals 2 and 3, and Wangfujing APM, among other core venues. To date, the Company has signed agreements with nearly 100 robotics companies as authorized agents.Market analysts note that the valuation logic for Shoucheng Holdings’ robotics business is transitioning from book valuations in the primary market toward more observable pricing in the capital markets. As a representative investment within Shoucheng Holdings’ robotics portfolio, Unitree Robotics—together with its IPO progress—provides the market with a clearer anchor for assessing the value of Shoucheng Holdings’ robotics assets.From a longer-term perspective, the data points of “more than RMB 2 billion invested, more than 20 companies covered, and portfolio valuation increasing approximately fourfold to around RMB 8 billion” already outline the basic contours of Shoucheng Holdings’ robotics strategy:At the front end, the Company secures leading projects through its funds.In the mid-stage, it accelerates commercialization through channels and service systems.At the back end, it opens up exit and re-rating opportunities through IPOs and capital operations.As projects such as Unitree Robotics move into the capital-market spotlight, the book value of Shoucheng Holdings’ robotics investments, its industrial synergy capabilities, and its subsequent monetization path are becoming increasingly clear. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform ACN Newswire

Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform

PHILADELPHIA, PA AND WILMINGTON, DE, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Datavault AI Inc. (NASDAQ:DVLT), an AI-driven data monetization, RWA tokenization, and Web 3.0 infrastructure company, and Demora Foundation, the Delaware-incorporated governing organization of the Demora Chain ecosystem (governed under JP3E Holdings Inc.), today announced the execution of a Technology Integration Agreement establishing Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform - the integrated K2Global + Demora Foundation ecosystem that converts Korean cultural IP, live entertainment, and K-Wave soft power into institutional-grade, on-chain financial products, deployed across three US Innovation K-Wave Cities: Atlanta (GA), Dallas (TX), and New York Tri-State.K-WAVE AUDIENCE SCALE200M+Global Hallyu Fans · 156 Countries$40B+K-Wave Annual Economic Impact (KOFICE 2024)$14B+K-Pop Revenue 2025E (Live + Streaming + Merch)120M+Dedicated K-Pop Concert Fans Globally500+Korean SMBs · 8 K-Wave Sectors · K2Global Mandate$3B+K-Entertainment Tokenizable Pipeline (DMR-LIVE)3US Innovation K-Wave Cities (ATL · DAL · NY Tri-State)8-14%Target DMR-LIVE Token Yield (Annualized)The Agreement deploys Datavault AI's full enterprise AI stack - Data Vault®, DataValue®, DataScore®, and Information Data Exchange® (IDE) Digital Twin - as the AI data intelligence and RWA/VWA tokenization backbone of Demora Chain, purpose-built to score, value, credentialize, and tokenize K-Entertainment assets - including K-Pop concert revenues, K-Drama IP royalties, K-content digital rights, K-Beauty brands, and K-Food franchises - as yield-bearing instruments settled in DMR (apex RWA) and GMMT (VWA layer) on Demora's dual OP Stack Layer 2.The K-Entertainment Opportunity - 200M+ Fans, $11B-$16B Annual Event Revenue, $3B+ Tokenizable PipelineThe Korean Wave (Hallyu) is the most scalable cultural export engine in the world - and the foundational demand signal for the entire DVLT × Demora Foundation partnership. With 200M+ Hallyu fans across 156 countries generating over $40B in annual economic impact, K-Entertainment represents an institutional-scale, pre-qualified audience base no other RWA protocol can access.K-Entertainment Audience & Tokenizable Pipeline - By VerticalK-Wave VerticalGlobal Fan BaseAnnual Event Revenue Est.Digital / Streaming LayerDMR-LIVE Tokenization OpportunityK-Pop Live Concerts & Tours120M+ dedicated fans$6B - $8B globallyWeverse, YouTube, streaming rights$1.5B+ addressableK-Drama & Film IP Events80M+ drama viewers$2B - $3B IP + premiere circuitNetflix, Disney+, local OTT licensing$600M+ addressableK-Food & Culinary Festivals50M+ global K-Food consumers$800M - $1.2B festivals/franchiseExport brands, franchise licensing$250M+ addressableK-Beauty Brand Events & Launches60M+ active K-Beauty consumers$1B - $1.5B experiential marketingD2C, influencer, brand collab$300M+ addressableGaming, Esports & Webtoon Festivals40M+ K-gaming & esports fans$1.2B - $2B event + IPStreaming, IP licensing, game merch$400M+ addressableTOTAL K-Entertainment TAM200M+ Hallyu Fans (composite)$11B - $16B annual event revenue$5B+ digital overlay$3B+ tokenizable pipelineDMR-LIVE Protocol - K-Entertainment RWA Tokenization EngineAt the core of the DVLT × Demora Foundation partnership is DMR-LIVE - the K-Entertainment RWA tokenization protocol that converts live event cash flows (ticket receivables, venue revenues, VIP hospitality, IP/sponsorship contracts) into yield-bearing digital assets settled on Demora Chain. Datavault AI provides the AI data intelligence layer that makes DMR-LIVE institutional-grade.DMR-LIVE - Projected Deployment & Deal ScalePhase 1 · 0-6 MonthsPilot Launch5-10 K-Wave flagship events (US + Korea)DMR-LIVE token launch on Demora Chain$25M - $50M initial pool issuance500K - 1M live attendeesInstitutional LP onboarding (Reg D)Phase 2 · 6-18 MonthsScale & Liquidity20-40 multi-genre eventsUS, Korea, Africa, SE Asia$100M - $300M issuance target3M - 8M live + digital viewersSWF / Ex-Im institutional channelPhase 3 · 18-36 MonthsGlobal Integration100+ events per annual cycleGlobal deployment (20+ countries)$300M+ annual issuance run-rate15M - 30M annual audienceNASDAQ SPAC pathway for K2GlobalDatavault AI - Powering K-Entertainment IP Intelligence & TokenizationDatavault AI's enterprise platform serves as the data intelligence layer that transforms K-Entertainment assets from illiquid cultural IP into institutional-grade, on-chain financial products:K-Pop & Content IP - IDE Digital Twin & NIL CredentialingOn-chain digital twin representations of K-Pop artist brands, K-Drama IP rights, digital content royalties, and NIL (Name, Image, Likeness) credentials - enabling programmable IP monetization and VWA issuance on GMMT layer.K-Entertainment Asset Valuation - DataScore® AI AgentsAI-based scoring and valuation of K-Pop artist tour revenue forecasts, K-Drama IP licensing streams, K-content streaming rights, and live event cash flow projections - providing the institutional-grade data oracle powering DMR-LIVE token pricing.Franchise & Brand Asset Scoring - DataValue®Comprehensive valuation scoring for K-Beauty brands, K-Food franchise systems, and K-Fashion design IP - preparing these assets for DMR-denominated RWA tokenization and cross-border distribution settlement on Demora Chain.Entertainment & Sports Vertical - HPC Software LicensingHigh-performance compute infrastructure for real-time K-Wave asset valuation, streaming rights scoring, and DMR-denominated tokenization at institutional scale - spanning K-Pop, K-Drama, K-Gaming, and K-Esports verticals.Provenance & Compliance - Data Vault® + Web 3.0 Immutable MetadataEnterprise data management and immutable provenance framework for K-Entertainment IP registrations, royalty flow traceability, and institutional-grade KYC/AML compliance aligned with Demora Chain's DMR settlement requirements.Global Digital Infrastructure Platform - Three-Layer ArchitectureThe DVLT partnership operates across the three-layer JP3E platform architecture - with K-Entertainment as the lead vertical:Platform LayerRole & DVLT Integration PointK2Global (Layer 3 - Application)Asset origination layer: 500+ Korean SMBs across 8 K-Wave sectors. K-Entertainment leads - K-Pop concert IP, K-Drama rights, K-Beauty brands, K-Food franchises. K2Global identifies the real-world and IP assets that DVLT's DataScore® and IDE Digital Twin will score, value, and credentialize for tokenization on Demora Chain.JP3E Holdings (Structure & Access)Institutional governance and capital structure layer. Structures regulatory compliance (Clean Wall separation), OTC → NASDAQ pathway, and sovereign capital access. DVLT's KYC/AML-compliant Web3 data management integrates at this governance layer.Demora Foundation (Layer 1 - Tokenize & Liquidate)Converts illiquid K-Entertainment and K-Wave infrastructure assets into tradable DMR-denominated RWA and GMMT-powered VWA instruments via Demora Chain's dual OP Stack Layer 2. DVLT's HPC-powered tokenization platform and immutable metadata framework are the core technology input at this layer - enabling LP waterfall yield + DMR token upside.K-Wave Cities Deployment - DVLT Integration by SectorThe Technology Integration Agreement positions Datavault AI as the enterprise data intelligence and tokenization technology partner across all eight K-Wave growth sectors in three US Innovation Cities - with K-Entertainment as the flagship commercial vertical:K-Wave SectorDVLT Platform ApplicationEntertainment - K-Pop, Drama IP, Digital Content & MediaFLAGSHIP VERTICAL - IDE Digital Twin & NIL credentialing for K-Pop artist IP, K-Drama content rights, and digital royalty tokenization as VWA on GMMT; DataScore® for AI-based content asset valuation and live event revenue forecasting; DMR-LIVE protocol integration for K-Pop concert receivables tokenization as RWA on DMRFood & Beverage - K-Food Franchise, Cuisine & ExportDataValue® for franchise system and supply chain asset scoring; J1Manna DMR RWA settlement for cross-border distribution contracts through Innovation City hubsBeauty & Cosmetics - K-Beauty Brands, Skincare & BiotechDVLT healthcare HPC licensing applied to K-Beauty O-Min, biotech supply chains; IDE Digital Twin for K-Longevity (NovocellBio NK cell) clinical supply RWA tokenizationTechnology / AI - IoT, Robotics & BlockchainDataScore® AI agents for KORECEN biometric patent (13 KIPO finger-vein) valuation as RWA; DVLT Web 3.0 enterprise data management for IoT/robotics SMB IP assetsManufacturing - Advanced Materials, EV Components & BatteriesDVLT immutable metadata for critical minerals provenance; IDE Digital Twin for K-Defense, dual-use hardware supply chain traceability on DMRHealthcare / Bio - Pharmaceuticals, Medical Devices & TelehealthDVLT healthcare HPC licensing and DataValue® for NovocellBio NK cell manufacturing capacity and clinical supply agreement tokenization as K-Longevity RWA on DMRFashion - Contemporary Design & Textile InnovationIDE NIL credentialing for brand and design IP; DataScore® for O-Min fashion IP asset valuation as VWA on GMMT; cross-border distribution RWA on DMREducation / EdTech - E-Learning Platforms & Global CertificationDVLT Web 3.0 data management for SaaS-model EdTech platform data assets; DataScore® for certification IP valuation feeding Demora flywheel programmable yield via DMRStatements"Datavault AI was built for exactly this moment - when AI-powered data intelligence meets institutional blockchain infrastructure at a global scale. The K2Global Innovation K-Wave platform, with K-Entertainment as its flagship vertical, represents one of the most compelling real-world asset mandates in the market today: 200M+ Hallyu fans, $14B+ in K-Pop revenue, 500+ Korean SMBs, three US Innovation Cities, and a two-token blockchain architecture built for institutional settlement. Our Data Vault®, DataValue®, DataScore®, and Digital Twin platforms are the intelligence layer that transforms K-Entertainment IP - from K-Pop concert revenues and K-Drama royalties to K-Beauty brands and K-Food franchises - from illiquid cultural assets into scalable, liquid digital financial products. We are proud to be the technology partner of choice for the JP3E platform."- Nathaniel Bradley, CEO, Datavault AI Inc. (NASDAQ: DVLT)"The Datavault AI partnership is a defining moment for the Global Digital Infrastructure Platform - and specifically for DMR-LIVE, our K-Entertainment RWA tokenization protocol. K-Entertainment is not merely one of eight K-Wave sectors; it is the cultural demand engine that drives all of them. With 200M+ Hallyu fans, $40B+ in annual K-Wave economic impact, and a $3B+ tokenizable K-Entertainment pipeline, DVLT's AI-powered data valuation, Digital Twin technology, and enterprise tokenization stack provide precisely the intelligence infrastructure required to convert Korean cultural IP into institutional-grade, on-chain financial products at global scale. Together, we are building the operating system for K-Wave infrastructure finance."- John K. Park, Chairman & CEO, Demora Foundation / JP3E Holdings Inc.About Datavault AI Inc. (NASDAQ: DVLT)Datavault AI Inc. (NASDAQ:DVLT) is an AI-driven data monetization, RWA tokenization, and Web 3.0 infrastructure company headquartered at One Commerce Square, 2005 Market Street, Suite 2400, Philadelphia, PA 19103. DVLT provides enterprise-grade platforms including Information Data Exchange® (Digital Twin / NIL credentialing), Data Vault®, DataValue®, and DataScore® AI agents, and HPC-powered data valuation and secure monetization infrastructure spanning fintech, healthcare, real estate, and sports & entertainment verticals - including the full K-Entertainment sector. CEO: Nathaniel Bradley. Website: www.datavaultsite.comAbout Demora FoundationDemora Foundation is the institutional governance entity of Demora Chain - a dual OP Stack Layer 2 on Ethereum (target: 560,000+ TPS, USD1 gas model) designed for stablecoin finance, RWA tokenization, and VWA (Virtual Wealth Asset) creation at institutional scale. Demora Foundation governs the DMR-LIVE K-Entertainment RWA tokenization protocol as the flagship product of its K2Global Innovation K-Wave Cities deployment. Demora Foundation is incorporated in Delaware and governed under JP3E Holdings Inc. Website: demora.foundationMedia Contacts:John K. Park, Chairman & CEO - JP3E Holdings Inc. / Demora FoundationJohn.park@jp3e.com | www.jp3e.com | demora.foundationAlan Wallace, Head of Public Relations - Datavault AI / marketing@dvlt.aiInvestor ContactEdward Barger, VP, Investor Relations - Datavault AI, ir@dvlt.ai - ebarger@dvlt.aiSOURCE: Datavault AI Inc Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
JDE Peet’s Goes Live with OMP’s Unison Planning(TM), Accelerating Supply Chain Value at Scale ACN Newswire

JDE Peet’s Goes Live with OMP’s Unison Planning(TM), Accelerating Supply Chain Value at Scale

ANTWERPEN, BELGIUM, Apr 1, 2026 - (ACN Newswire via SeaPRwire.com) - OMP, a leader in supply chain planning solutions, has partnered with global pure-play coffee leader JDE Peet's to deliver advanced end-to-end supply chain planning. With Unison Planning™ now live, JDE Peet's will improve planning accuracy, reduce inventory costs, and improve overall agility.The go-live marks the first wave of IRIS (Intelligent, Responsive, and Integrated Supply Chain Planning), JDE Peet's transformation program to advanced supply chain planning. Designed to optimize end-to-end planning processes and cross-functional collaboration, IRIS aims to accelerate agility and improve decision-making in an increasingly challenging coffee market. The program is being rolled out toward manufacturing units and markets globally through 2026.Improving planning accuracy, reducing costs, and boosting agilityOver eighteen months, JDE Peet's developed a new supply chain planning framework in close collaboration with business integrator EY and OMP's consumer goods experts, implementing demand and supply planning across an initial set of EU markets and manufacturing units.Abel Martinez, JDE Peet's Global Supply Chain Director, highlights the impact: "OMP's Unison Planning gives us end-to-end visibility and integrates demand and supply planning, improving planning accuracy. It will help us reduce inventory, cut storage costs, and safeguard service levels. Smarter planning is enabling us to prevent waste across the business.""With better end-to-end visibility and smarter supply planning, we're reducing inventory levels, cutting storage costs, and avoiding obsolescence."Building toward advanced decision intelligenceAs the rollout continues, the program will expand to include integrated business planning with advanced scenario capabilities, progressively introducing AI-driven optimization and decision intelligence.Gerwalt Stoffels, OMP's Senior Vice President for Consumer Goods: "It's great to see how focused everyone is on creating business value. This project stands out for its targeted realism, immediately delivering foundational capabilities that drive real results, then progressively working toward more ambitious goals such as decision-centric and touchless planning."Gerwalt Stoffels, OMP's Senior Vice President for Consumer Goods: "It's great to see how focused everyone is on creating business value. This project stands out for its targeted realism, immediately delivering foundational capabilities that drive real results, then progressively building toward more advanced and ambitious goals.""What makes this project stand out is its targeted realism, with decision-centric and value-driven planning on the horizon."About JDE Peet'sJDE Peet's is the world's leading pure-play coffee company, serving approximately 3,900 cups of coffee per second in more than 100 markets. Guided by our ‘Reignite the Amazing' strategy, we are focusing on brand-led growth across three big bets: Peet's, L'OR, and Jacobs, alongside a collection of 9 local icons. In 2025, JDE Peet's generated total sales of EUR 9.9 billion and employed a global workforce of more than 21,000 employees.About OMPOMP helps companies facing complex planning challenges to excel, grow, and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries - spanning consumer goods, life sciences, chemicals, metals, paper, packaging, plastics - benefit from using OMP's unique Unison Planning™.Solution and product inquiriesContact OMPMedia inquiriesKira Perdue (Carabiner)SOURCE: OMP Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
Honda Makes Gachaco a Consolidated Subsidiary by Subscribing to New Shares of Gachaco Issued Through Third-party Allotment JCN Newswire

Honda Makes Gachaco a Consolidated Subsidiary by Subscribing to New Shares of Gachaco Issued Through Third-party Allotment

TOKYO, Japan, Apr 1, 2026 - (JCN Newswire via SeaPRwire.com) - Honda Motor Co., Ltd. (Honda) today announced that it has subscribed to new shares of Gachaco, Inc. (Gachaco) issued through a third-party allotment (“this transaction”), thereby making Gachaco a consolidated subsidiary of Honda.Gachaco was established in April 2022 as a joint venture of five companies in Japan — Honda, ENEOS Holdings, Kawasaki Motors, Ltd., Suzuki Motor Corporation and Yamaha Motor Co., Ltd. — to provide a sharing service of standardized swappable batteries for electric motorcycles and to establish and maintain infrastructure for such sharing services.Since October 2022, Gachaco has been installing Gachaco battery swapping stations primarily in Tokyo, where electric motorcycle users with a Gachaco membership can efficiently swap a depleted battery for a fully charged one whenever needed, without any waiting time for charging. The company has rolled out the service in urban areas of Tokyo, starting with corporate customers and, in January 2024, the service was expanded to individual customers as well. Gachaco has been building out its infrastructure to create an environment where anyone can use electric motorcycles without worrying about charging time and riding range. Currently, the company is expanding its network of Gachaco stations, primarily in Tokyo and Osaka, while also pursuing the establishment of a next-generation energy infrastructure that contributes to a decarbonized and circular society.Honda is striving to achieve carbon neutrality for all products and corporate activities Honda is involved in by 2050, and one of the key initiatives toward this goal is the popularization of electric mobility products. In addition to expanding the lineup of electric models, Honda believes that it is important to build battery charging and supply networks so that people can use their electric motorcycles with peace of mind; therefore, Honda has been considering Gachaco as an important partner for realizing such a future. Going forward, in order to continue to enhance the usage environment for electric motorcycle products, Honda realized that a motorcycle manufacturer needs to take the lead in this initiative. Based on this reasoning, Honda has decided to acquire additional shares in Gachaco.As a subsidiary of Honda, Gachaco will further accelerate its ongoing initiatives to build battery charging and supply networks and work to expand its battery sharing service for users of electric construction machinery and equipment powered by swappable batteries. In addition, Gachaco will work to offer rental and maintenance services for battery swapping stations to be installed on the premises of business facilities of corporate customers with large fleets of electric motorcycles. Through these initiatives, Honda will lead the growth of Gachaco business and establish an environment where more customers can use electric mobility products safely with complete peace of mind.Overview of the transactionClass of subscribed sharesCommon shares of Gachaco Inc.Number of subscribed shares340,000 sharesAmount to be paid340,000,000 yenHonda shareholding ratio after the transaction47%About GachacoCompany nameGachaco Inc.Location4F, THE CORNER Shibakoen,2-8-2 Shibakoen, Minato-ku, Tokyo 1050011, JapanEstablishedApril 1, 2022RepresentativeMasahide Hirose, PresidentShareholdersHonda Motor Co., Ltd.,ENEOS Innovation Partners Godo Kaisha*,Suzuki Motor Corporation,Yamaha Motor Co., Ltd.,Kawasaki Motors, Ltd.,BusinessOperation of battery charging/swapping stations to achieve widespread useand broader applications of standardized swappable batteries*ENEOS Holdings, Inc. has invested in Gachaco through its investment company, ENEOS Innovation Partners Godo KaishaGachaco station Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut
GMG Verified by Advanced Carbons Council & Successful ISO9001 Audit ACN Newswire

GMG Verified by Advanced Carbons Council & Successful ISO9001 Audit

BRISBANE, AUS, Apr 1, 2026 - (ACN Newswire via SeaPRwire.com) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased that the Advanced Carbons Council (the "ACC") has certified GMG as a Verified Graphene Producer.The Verified Graphene Producer program is an independent 3rd party verification by the ACC of not just the material, but it includes an in-person visit of the production facilities. This makes it unique in that the ACC verify the source of the material as coming directly from the production stream while using world-class characterization labs to test the material.To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/8082/290829_3bb80a87648f4a4f_001full.jpgThe Verified Graphene Producer program follows the Graphene Classification Framework (GCF) and the currently published international standards, including: ISO/TS 9651:2025 Nanotechnologies - Classification framework for graphene-related 2D materials, ISO/TR 19733:2019(E), Nanotechnologies - Matrix of properties and measurement techniques for graphene and related two dimensional (2D) materials, ISO/TS 80004-13:2017(E) Nanotechnologies - Vocabulary - Part 13: Graphene and related two-dimensional (2D) materials and ISO/TS 21356-1:2021(E) Nanotechnologies - Structural characterization of graphene - Part 1: Graphene from powders and dispersionsThe Company is also pleased to announce it has successfully passed another ISO9001:2015 quality audit of the organisation for the manufacturing, distributing, and providing technical support for the Company's graphene coating and lubricant additive products. Figure 1 shows the certificate. ISO 9001 is the internationally recognized standard for Quality Management Systems (QMS). It provides a framework for organizations to ensure products and services consistently meet customer and regulatory requirements while focusing on continual improvement. It is applicable to any industry or business size, focusing on quality control, efficiency, and risk management.Terrance Barkan, Executive Director of the Advanced Carbons Council, commented "We are proud to count Graphene Manufacturing Group (GMG) as the newest member of a select group of graphene companies to have passed a rigorous in-person inspection of their facilities and a thorough examination of their graphene material. Independent, third party validation through the Verified Graphene Producer program is an incredibly valuable tool for customers, investors and other stakeholders when choosing a graphene producer/supplier. "Figure 1: GMG's ISO9001 Quality Management Standards CertificationTo view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/8082/290829_3bb80a87648f4a4f_002full.jpgCraig Nicol, CEO & Managing Director of the Company, commented "Verification by the Advanced Carbon Council as one of five currently verified global graphene producers is another proof of the high quality of our graphene and why our graphene products function at such a world leading standard and our quality system audit successful outcome shows our ability to turn this into a real product manufacturing business."Jack Perkowski, Chairman and Non-Executive Director of the Company, commented: "Congratulations to the team on getting this third-party verification on the graphene and quality management system - a real table stake when it comes to producing carbon nano material products".About Advanced Carbons Council: The Advanced Carbons Council (ACC) is the global trade association that supports the production, adoption and use of engineered advanced carbons. Our mission is to connect and facilitate the cross-sector fertilization of ideas, applications and business for all advanced materials producers and users. Our Members are companies and organizations that produce, use and develop applications for: Graphene, Carbon Nanotubes (CNTs), Carbon Nanofibers, Carbon Fiber, Synthetic and Engineered Graphite, Carbon-Carbon Composites, Carbon Nanodiamonds (CNDs), Fullerenes, MXenes and new carbon forms, Recycled and Reclaimed Carbons. Delivered by the same team that has grown and developed The Graphene Council over the past 12 years to become a global community of more than 40,000 materials professionals, the ACC focuses on standards, quality, safety, education, sustainability, advocacy, verification, testing and outreach to connect users with qualified supply chain partners.About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed at improving the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "believes" "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, the fact that ACC's Verified Graphene Producer program is unique, that it follows the Graphene Classification Framework and international standards, the applicability of the ISO9001 to GMG, its suitability for any industry or business size and its focus, the quality of GMG's graphene, its functioning at a world leading standard, and its ability to turn its quality system into a successful product manufacturing business.Such forward-looking statements are based on a number of assumptions of management. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation that GMG does not receive or receive on a timely basis the fully signed consent notice from the and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 4, 2025 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290829 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Lebih lanjut
DENSO Hosted “DENSO DIALOG DAY 2026”,  Delivers Mid-Term Management Plan “CORE 2030” JCN Newswire

DENSO Hosted “DENSO DIALOG DAY 2026”, Delivers Mid-Term Management Plan “CORE 2030”

KARIYA, JAPAN, Apr 1, 2026 - (JCN Newswire via SeaPRwire.com) - DENSO CORPORATION, a leading mobility supplier, held the “Mid-Term Management Plan Briefing: DENSO DIALOG DAY 2026” (hereinafter, “Dialog Day”) on March 31, 2026.At the briefing, DENSO provided an overview of its Mid-Term Management Plan “CORE 2030” (hereinafter, “CORE 2030”), which was announced on the same day. Shinnosuke Hayashi, President & CEO, Yasushi Matsui, Executive Vice President, and Yasuhiko Yamazaki, Executive Vice President explained DENSO’s vision for 2030 and the strategies, while also engaging in direct dialogue with investors, analysts, and the media.Through presentations and opportunities for dialogue, DENSO will continue to communicate the strategies set out in “CORE 2030” more concretely and work together with society, customers, and partners to create new value.For details of “CORE 2030,” please refer to the timely disclosure material announced on March 31, 2026, as well as the briefing materials, and Mid-Term Management Plan page on the corporate website.- Timely Disclosure MaterialNotice Regarding the Formulation of the Mid-Term Management Plan “CORE 2030” (March 31, 2026)- Briefing Materialshttps://www.denso.com/global/en/about-us/investors/business-briefing/- Corporate Website: Mid-Term Management Plan “CORE 2030”https://www.denso.com/global/en/about-us/corporate-info/policy/mid-term_management_plan2030/Speech by Shinnosuke Hayashi, President & CEODialogue Session From left: Hirotsugu Takeuchi, Senior Executive Officers and Chief Technology Officer (CTO) Yasushi Matsui, Executive Vice President Shinnosuke Hayashi, President & CEO Yasuhiko Yamazaki, Executive Vice PresidentFor more information, visit https://www.denso.com/global/en/news/newsroom/2026/20260401-g03/. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Lebih lanjut